Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • Everstone acquires...

    Everstone acquires stake in Chennai based CPC Diagnostics

    GarimaWritten by Garima Published On 2019-03-14T16:59:18+05:30  |  Updated On 16 Aug 2021 4:22 PM IST

    The strategic partnership with Everstone Group will help CPC Diagnostics take its product portfolio to new customers and markets, the Chennai-based company's managing director R Kailasnath said in a statement.


    Mumbai: In a strategic move to augment its presence in India, Private equity firm, Everstone Group has acquired a stake in Chennai-based CPC Diagnostics via its pan-Asian healthcare platform, Everlife. The acquisition intends to include core in-vitro diagnostics (IVD) segments in its portfolio of medical devices.


    Everstone had launched Everlife in late 2017. Everlife invests in manufacturers and distributors in segments such as in-vitro diagnostics, medical diagnostics, critical care equipment, implants and consumables.


    The company said in a statement that the current acquisition will help Everlife, with this first investment in the country to include core in-vitro diagnostics segments in its portfolio of medical devices and expand its presence to India.


    The in-vitro diagnostics (IVD) segment is one of the largest within the medical devices market.


    Arjun Oberoi, Vice Chairman, Everlife and Managing Director (MD) of Everstone Capital said, "We are delighted to invest in CPC Diagnostics and help scale up its presence across the diagnostics sector."


    "Its strong manufacturing and R&D capabilities make them an ideal partner for us and we will help them expand in markets beyond India. Everlife can also leverage on CPC to grow its value segment range of products, to cater to the growing demand of quality medical devices within emerging markets," Oberoi added.


    Commenting on the same, R Kailasnath, Managing Director, CPC Diagnostics said that Everlife is creating a pan-South Asian and South-East Asian distribution and manufacturing platform for IVD and other laboratory/medical device segments.


    The strategic partnership will help CPC Diagnostics take its product portfolio to new customers and markets, the Chennai-based company's managing director R Kailasnath said in a statement.


    Founded in 1987, CPC Diagnostics is a medical devices manufacturer and distributor with presence across India, Sri Lanka and Bangladesh, and exports to countries in the Middle East and Europe. It supplies a wide range of products and services to research and clinical laboratories.


    Also Read: Everstone buys Malaysian medical devices company Chemopharm

    AcquistionArjun OberoiCPC DiagnosticsdiagnosticsEverlifeEverstoneeverstone capitalExpansionIn Vitro DiagnosticsIndiaIVDMedical DevicesR Kailasnath
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Garima
    Garima

      Garima joined Medical Dialogues in the year 2017 and is currently working as a Senior Editor. She looks after all the Healthcare news pertaining to Medico-legal cases, MCI/DCI decisions, Medical Education issues, government policies as well as all the news and updates concerning Medical and Dental Colleges in India. She is a graduate from Delhi University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok